Nurse Practitioner, Family · San Antonio, TX
NPI
1497183529
Since 2013
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
4751 Hamilton Wolfe Rd Ste 200
San Antonio, TX, 78229
Phone (210) 233-7126
Groups this clinician bills Medicare through
Medicare paid, 2023
$73K
1,110 services
Medicare patients, 2023
390
Average age 74
Drug cost, 2024
$28.2M
2,881 prescriptions
Company payments, 2025
$53.42
From 1 companies
Procedures and visits billed to Original Medicare, 2023
In 2023, the most common Medicare service billed by Jamiel Ramos was code 99232 (hospital e&m - subsequent), 386 times for 188 patients. In total Jamiel Ramos billed 1,110 services in 23 codes, and Medicare paid $73K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-01-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 386 | 188 | $51.30 | $20K |
| 99233 Hospital E&M - Subsequent | Facility | 202 | 85 | $77.45 | $16K |
| 99222 Hospital E&M - Initial | Facility | 163 | 156 | $83.00 | $14K |
| 99309 SNF E&M | Office | 89 | 32 | $69.23 | $6,161 |
| 99223 Hospital E&M - Initial | Facility | 57 | 54 | $112.89 | $6,435 |
| 99308 SNF E&M | Office | 41 | 23 | $48.24 | $1,978 |
| 11042 Debridement | Facility | 32 | 22 | $35.97 | $1,151 |
| 99305 SNF E&M | Office | 27 | 26 | $86.57 | $2,337 |
| 99231 Hospital E&M - Subsequent | Facility | 23 | 22 | $32.23 | $741 |
| 99214 Office E&M - Established | Facility | 14 | 13 | $54.30 | $760 |
| 99306 SNF E&M | Office | 12 | 12 | $118.42 | $1,421 |
By year: 2022 $90K for 1,429 services; 2023 $73K for 1,110 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jamiel Ramos prescribed most often to Medicare patients was Dupixent Pen (Dupilumab), with 395 prescriptions and refills. In total Jamiel Ramos wrote 2,881 Medicare prescriptions that cost $28.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dupixent Pen Dupilumab | 395 | 409 | 71 | $1.5M |
| Otezla Apremilast | 379 | 401 | 71 | $1.9M |
| Xifaxan Rifaximin | 307 | 313 | 92 | $968K |
| Epclusa Sofosbuvir/Velpatasvir | 294 | 294 | 104 | $7.0M |
| Skyrizi Pen Risankizumab-Rzaa | 276 | 699 | 111 | $5.5M |
| Cosentyx Sensoready (2 Pens) Secukinumab | 235 | 242 | 39 | $1.9M |
| Taltz Autoinjector Ixekizumab | 181 | 200 | 37 | $1.4M |
| Humira(Cf) Pen Adalimumab | 132 | 137 | 20 | $908K |
| Cosentyx Unoready Pen Secukinumab | 92 | 92 | 16 | $882K |
| Tremfya Guselkumab | 85 | 152 | 25 | $1.1M |
| Sotyktu Deucravacitinib | 63 | 65 | 14 | $418K |
| Stelara Ustekinumab | 50 | 124 | 23 | $881K |
| Bimzelx Autoinjector Bimekizumab-Bkzx | 43 | 47 | Under 11 | $631K |
| Vemlidy Tenofovir Alafenamide | 40 | 44 | 13 | $59K |
| Skyrizi Risankizumab-Rzaa | 36 | 97 | 13 | $697K |
Brand drugs: 2,847 claims; generic drugs: 34 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jamiel Ramos $53.42 ($53.42 in general payments such as food, travel and fees) from 1 company. The largest payer was Gilead Sciences, Inc. with $53.42.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 3 | $53.42 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.